The global medical adhesive market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 3.2 billion by 2030. The growth of this market is driven by factors such as increasing demand for minimally invasive surgeries and rising incidence of chronic diseases, which are driving the need for surgical procedures.
Soft tissue medical adhesives are expected to be the fastest-growing segment in this market during the forecast period, with a CAGR of 5%. This growth can be attributed to factors such as increasing demand for minimally invasive surgeries and rising incidence of chronic diseases, which are driving the need for surgical procedures.
Some Of The Growth Factors Of This Market:
- Increasing awareness about the benefits of high-strength medical adhesives over conventional ones is also driving the growth of this market globally.
- High-strength medical adhesives are used in various applications such as wound closure, surgical procedures, and orthopedic surgeries which are expected to drive their demand in the near future due to their ability to provide strong bonding with minimal scarring or tissue damage during removal process.
Industry Growth Insights published a new data on “High-Strength Medical Adhesive Market”. The research report is titled “High-Strength Medical Adhesive Market research by Types (Soft Tissue Medical Adhesive, Hard Tissue Adhesive, Hard Tissue Adhesive), By Applications (Hospital, Clinic), By Players/Companies Abbott Laboratories, BD, bioMerieux, Bio-Rad Laboratories, Thermo Fisher Scientific, Beckman Coulter, Fenwal, Fresenius Kabi, Grifols International, Haemonetics, Immucor, Macopharma, Roche, Stago”.
Scope Of The Report
Report Attributes
Report Details
Report Title
High-Strength Medical Adhesive Market Research Report
By Type
Soft Tissue Medical Adhesive, Hard Tissue Adhesive, Hard Tissue Adhesive
By Application
Hospital, Clinic
By Companies
Abbott Laboratories, BD, bioMerieux, Bio-Rad Laboratories, Thermo Fisher Scientific, Beckman Coulter, Fenwal, Fresenius Kabi, Grifols International, Haemonetics, Immucor, Macopharma, Roche, Stago
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global High-Strength Medical Adhesive Market Report Segments:
The global High-Strength Medical Adhesive market is segmented on the basis of:
Types
Soft Tissue Medical Adhesive, Hard Tissue Adhesive, Hard Tissue Adhesive
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- BD
- bioMerieux
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Beckman Coulter
- Fenwal
- Fresenius Kabi
- Grifols International
- Haemonetics
- Immucor
- Macopharma
- Roche
- Stago
Highlights of The High-Strength Medical Adhesive Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Soft Tissue Medical Adhesive
- Hard Tissue Adhesive
- Hard Tissue Adhesive
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the High-Strength Medical Adhesive Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
High-strength medical adhesive is a type of medical adhesive that is designed to be stronger than other types of medical adhesives. This makes it ideal for use in areas where durability and strength are important, such as during surgery or when attaching devices to the body.
Some of the major companies in the high-strength medical adhesive market are Abbott Laboratories, BD, bioMerieux, Bio-Rad Laboratories, Thermo Fisher Scientific, Beckman Coulter, Fenwal, Fresenius Kabi, Grifols International, Haemonetics, Immucor, Macopharma, Roche, Stago.
The high-strength medical adhesive market is expected to grow at a compound annual growth rate of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. High-Strength Medical Adhesive Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. High-Strength Medical Adhesive Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. High-Strength Medical Adhesive Market - Supply Chain
4.5. Global High-Strength Medical Adhesive Market Forecast
4.5.1. High-Strength Medical Adhesive Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. High-Strength Medical Adhesive Market Size (000 Units) and Y-o-Y Growth
4.5.3. High-Strength Medical Adhesive Market Absolute $ Opportunity
5. Global High-Strength Medical Adhesive Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. High-Strength Medical Adhesive Market Size and Volume Forecast by Type
5.3.1. Soft Tissue Medical Adhesive
5.3.2. Hard Tissue Adhesive
5.3.3. Hard Tissue Adhesive
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global High-Strength Medical Adhesive Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. High-Strength Medical Adhesive Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global High-Strength Medical Adhesive Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. High-Strength Medical Adhesive Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global High-Strength Medical Adhesive Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. High-Strength Medical Adhesive Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global High-Strength Medical Adhesive Demand Share Forecast, 2019-2026
9. North America High-Strength Medical Adhesive Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America High-Strength Medical Adhesive Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America High-Strength Medical Adhesive Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America High-Strength Medical Adhesive Market Size and Volume Forecast by Type
9.7.1. Soft Tissue Medical Adhesive
9.7.2. Hard Tissue Adhesive
9.7.3. Hard Tissue Adhesive
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America High-Strength Medical Adhesive Demand Share Forecast, 2019-2026
10. Latin America High-Strength Medical Adhesive Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America High-Strength Medical Adhesive Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America High-Strength Medical Adhesive Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America High-Strength Medical Adhesive Market Size and Volume Forecast by Type
10.7.1. Soft Tissue Medical Adhesive
10.7.2. Hard Tissue Adhesive
10.7.3. Hard Tissue Adhesive
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America High-Strength Medical Adhesive Demand Share Forecast, 2019-2026
11. Europe High-Strength Medical Adhesive Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe High-Strength Medical Adhesive Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe High-Strength Medical Adhesive Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe High-Strength Medical Adhesive Market Size and Volume Forecast by Type
11.7.1. Soft Tissue Medical Adhesive
11.7.2. Hard Tissue Adhesive
11.7.3. Hard Tissue Adhesive
11.8.Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe High-Strength Medical Adhesive Demand Share, 2019-2026
12. Asia Pacific High-Strength Medical Adhesive Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific High-Strength Medical Adhesive Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific High-Strength Medical Adhesive Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific High-Strength Medical Adhesive Market Size and Volume Forecast by Type
12.7.1. Soft Tissue Medical Adhesive
12.7.2. Hard Tissue Adhesive
12.7.3. Hard Tissue Adhesive
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific High-Strength Medical Adhesive Demand Share, 2019-2026
13. Middle East & Africa High-Strength Medical Adhesive Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa High-Strength Medical Adhesive Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa High-Strength Medical Adhesive Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa High-Strength Medical Adhesive Market Size and Volume Forecast by Type
13.7.1. Soft Tissue Medical Adhesive
13.7.2. Hard Tissue Adhesive
13.7.3. Hard Tissue Adhesive
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa High-Strength Medical Adhesive Demand Share, 2019-2026
14. Competition Landscape
14.1. Global High-Strength Medical Adhesive Market: Market Share Analysis
14.2. High-Strength Medical Adhesive Distributors and Customers
14.3. High-Strength Medical Adhesive Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. BD
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. bioMerieux
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bio-Rad Laboratories
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Thermo Fisher Scientific
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Beckman Coulter
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Fenwal
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Fresenius Kabi
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Grifols International
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Haemonetics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Immucor
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Macopharma
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Roche
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Stago
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
